Search Results - "Barbaut, X"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Comparisons between Antimicrobial Pharmacodynamic Indices and Bacterial Killing as Described by Using the Zhi Model by CORVAISIER, S, MAIRE, P. H, BOUVIER D'YVOIRE, M. Y, BARBAUT, X, BLEYZAC, N, JELLIFFE, R. W

    Published in Antimicrobial Agents and Chemotherapy (01-07-1998)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2

    The Hill equation: a review of its capabilities in pharmacological modelling by Goutelle, Sylvain, Maurin, Michel, Rougier, Florent, Barbaut, Xavier, Bourguignon, Laurent, Ducher, Michel, Maire, Pascal

    Published in Fundamental & clinical pharmacology (01-12-2008)
    “…The Hill equation was first introduced by A.V. Hill to describe the equilibrium relationship between oxygen tension and the saturation of haemoglobin. In…”
    Get full text
    Journal Article
  3. 3

    Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control by Jelliffe, R W, Schumitzky, A, Van Guilder, M, Liu, M, Hu, L, Maire, P, Gomis, P, Barbaut, X, Tahani, B

    Published in Therapeutic drug monitoring (01-10-1993)
    “…The role of population pharmacokinetic modeling is to store experience with drug behavior. The behavior of the model is then correlated with the clinical…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6

    Model-based, goal-oriented, individualised drug therapy : Linkage of population modelling, new 'multiple model' dosage design, Bayesian feedback and individualised target goals by JELLIFFE, R. W, SCHUMITZKY, A, BAYARD, D, MILNAN, M, VAN GUILDER, M, WANG, X, JIANG, F, BARBAUT, X, MAIRE, P

    Published in Clinical pharmacokinetics (1998)
    “…This article examines the use of population pharmacokinetic models to store experiences about drugs in patients and to apply that experience to the care of new…”
    Get full text
    Journal Article
  7. 7

    Computation of drug concentrations in endocardial vegetations in patients during antibiotic therapy by Maire, P, Barbaut, X, Vergnaud, J M, el Brouzi, M, Confesson, M A, Pivot, C, Chuzeville, M, Ivanoff, N, Brazier, J L, Jelliffe, R W

    “…The treatment of endocarditis often requires prolonged antibiotic therapy. Individualized drug dosage regimens have made such therapy possible even in patients…”
    Get more information
    Journal Article
  8. 8

    Aminoglycoside determinations calculated in endocarditis vegetations. Relations with clinical practices during infectious endocarditis treatment with amikacin by Confesson, M A, Barbaut, X, Maire, P, Vergnaud, J M, el Brouzi, A, Jelliffe, R W

    Published in Therapie (01-01-1994)
    “…Using a new computer program SPHERE, amikacin concentrations have been computed at various layers of simulated endocardial vegetations. Inputs are the computed…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Adaptive control of therapeutic drug regimens relations between clinical situations: outcomes and simulations using nonlinear dynamic models by Maire, P H, Barbaut, X, Thalabard, J C, Vergnaud, J M, Roux, D, Roy, M, Jelliffe, R W

    Published in Medinfo. MEDINFO (1995)
    “…With Bayesian modeling and adaptive control of drug dosage regimens, serum and peripheral drug concentrations can be predicted in clinical situations using…”
    Get more information
    Journal Article